Should Expectations about the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations about Treatment Benefits?

BACKGROUND: Many analyses of HIV treatment decisions assume a fixed formulary of HIV drugs. However, new drugs are approved nearly twice a year, and the rate of availability of new drugs may affect treatment decisions, particularly when to initiate antiretroviral therapy (ART). OBJECTIVES: To determ...

Descripción completa

Detalles Bibliográficos
Autores principales: Khademi, Amin, Braithwaite, R. Scott, Saure, Denis, Schaefer, Andrew J., Nucifora, Kimberly, Roberts, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070901/
https://www.ncbi.nlm.nih.gov/pubmed/24963883
http://dx.doi.org/10.1371/journal.pone.0098354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070901/
https://www.ncbi.nlm.nih.gov/pubmed/24963883
http://dx.doi.org/10.1371/journal.pone.0098354

Ejemplares similares